Farnesyl pyrophosphate (Farnesyl diphosphate) ammonium is a metabolic intermediate in the mevalonate (MVA) pathway and acts as a TRP channel (TRPM2) agonist, triggering Ca2+ influx and cell death. This compound is a critical branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. It is utilized in research concerning cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.
- Metabolic intermediate in the mevalonate (MVA) pathway.
- TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death.
- Key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis.
- Used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.